Literature DB >> 29396056

Inflammation in human carotid atheroma plaques.

Haize Goikuria1, Koen Vandenbroeck2, Iraide Alloza3.   

Abstract

Inflammation in carotid atherosclerotic plaque is linked to plaque rupture and cerebrovascular accidents. The balance between pro- and anti-inflammatory mediators governs development of the plaque, and may mediate enhancement of lesion broadening or, on the contrary, delay progression. In addition to macrophages and endothelial cells, smooth muscle cells (SMCs), which are the dominant cell subset in advanced plaques, are crucial players in carotid atherosclerosis development given their ability to differentiate into distinct phenotypes in reponse to specific signals received from the environment of the lesion. Carotid atheroma SMCs actively contribute to the inflammation in the lesion because of their acquired capacity to produce inflammatory mediators. We review the successive stages of carotid atheroma plaque formation via fatty streak early-stage toward more advanced rupture-prone lesions and document involvement of cytokines and chemokines and their cellular sources and targets in plaque progression and rupture.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Carotid; Cytokine; Interleukin; Smooth muscle cell; TNF

Mesh:

Substances:

Year:  2018        PMID: 29396056     DOI: 10.1016/j.cytogfr.2018.01.006

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  8 in total

1.  Cyclophilins in Ischemic Heart Disease: Differences Between Acute and Chronic Coronary Artery Disease Patients.

Authors:  Jeremias Bayon; Amparo Alfonso; Sandra Gegunde; Eva Alonso; Rebeca Alvarino; Melisa Santas-Alvarez; Ana Testa-Fernandez; Ramon Rios-Vazquez; Luis Botana; Carlos Gonzalez-Juanatey
Journal:  Cardiol Res       Date:  2020-08-01

2.  Identification of Biomarkers of Autophagy-Related Genes Between Early and Advanced Carotid Atherosclerosis.

Authors:  Yuanyuan Zhang; He Zhang
Journal:  Int J Gen Med       Date:  2022-05-31

Review 3.  CD100 Effects in Macrophages and Its Roles in Atherosclerosis.

Authors:  Maria C A Luque; Mariana K Galuppo; Janaina Capelli-Peixoto; Beatriz S Stolf
Journal:  Front Cardiovasc Med       Date:  2018-09-28

4.  High Serum Cyclophilin C levels as a risk factor marker for Coronary Artery Disease.

Authors:  Amparo Alfonso; Jeremías Bayón; Sandra Gegunde; Eva Alonso; Rebeca Alvariño; Melisa Santás-Álvarez; Ana Testa-Fernández; Ramón Rios-Vázquez; Carlos González-Juanatey; Luis M Botana
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

5.  BIRC6 Is Associated with Vulnerability of Carotid Atherosclerotic Plaque.

Authors:  Iraide Alloza; Andrea Salegi; Jorge Mena; Raquel Tulloch Navarro; César Martin; Patricia Aspichueta; Lucía Martínez Salazar; Jon Uriarte Carpio; Patricia De-la-Hera Cagigal; Reyes Vega; Juan Carlos Triviño; Maria Del Mar Freijo; Koen Vandenbroeck
Journal:  Int J Mol Sci       Date:  2020-12-09       Impact factor: 5.923

6.  Increase of serum cyclophilin C levels in the follow-up of coronary artery disease: A biomarker and possible clinical predictor.

Authors:  Jeremías Bayón; Amparo Alfonso; Melisa Santás-Álvarez; Eva Alonso; Ana Testa-Fernández; Ramón Ríos-Vázquez; Raymundo Ocaranza-Sánchez; Rosa A Abellás-Sequeiros; Juliana Elices-Teja; Luis Botana; Carlos González-Juanatey
Journal:  Arch Cardiol Mex       Date:  2022-04-04

Review 7.  Natural Flavonoids Derived From Fruits Are Potential Agents Against Atherosclerosis.

Authors:  Ruo-Lan Li; Ling-Yu Wang; Shuqin Liu; Hu-Xinyue Duan; Qing Zhang; Ting Zhang; Wei Peng; Yongliang Huang; Chunjie Wu
Journal:  Front Nutr       Date:  2022-03-24

8.  MicroRNA-217 attenuates intima-media complex thickness of ascending aorta measured by ultrasound bio-microscopy and inhibits inflammation and lipid metabolism in atherosclerotic models of ApoE-/- mice.

Authors:  Haina Liu; Xia Li; Yanpeng Song; Zhibin Wang
Journal:  Lipids Health Dis       Date:  2018-07-24       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.